Biorthex Inc. Website: www.biorthex.com Biorthex, Inc. is a public (not listed on any stock exchange), Canadian medical device company located in Montreal (Quebec), with a particular focus of expertise in the spinal area. Biorthex’s patented Actipore technology platform is a porous nitinol, which forms a TiNi intermetallic molecule with excellent biological and biomechanical compatibility. TiNi material in its solid form, nitinol, has been known and approved by the FDA and used clinically in other medical devices worldwide for over a decade. Nitinol is known for its biocompatibility and its shape memory properties. Biorthex, with its worldwide patent protection on porous nitinol, is the first and only company to introduce nitinol in a porous form. Its biocompatibility makes it an ideal material for those applications where rapid and permanent bone attachment and integration is desirable such as spinal implants, dental prostheses, hip and knee implants, etc. The company’s other leading technology is the Orthobiom, a unique differentiated spinal implant indicated for the correction or alleviation of spinal deformities and degeneration. Orthobiom’s unique value is it’s the only spinal system dedicated to the treatment of scoliosis, without vertebral fusion.